1. Up front

   Up Front 26 July 2019 Pages: 1521 - 1522

   

2. Myokines in metabolic homeostasis and diabetes

   • Jürgen Eckel

   Review 01 July 2019 Pages: 1523 - 1528

   

3. Clinical aspects of heart failure in individuals with diabetes

   • Christa D. Bowes
   • Lillian F. Lien
   • Javed Butler

   Review 24 July 2019 Pages: 1529 - 1538

   

4. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism

   • Stephanie Eid
   • Kelli M. Sas
   • Patrice E. Fort

   Review 25 July 2019 Pages: 1539 - 1549

   

5. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals

   • Toshiaki Ohkuma
   • Yuji Komorita
   • Mark Woodward

   Article Open access 18 July 2019 Pages: 1550 - 1560

   

6. Neurocognitive and behavioural outcomes in offspring exposed to maternal pre-existing diabetes: a systematic review and meta-analysis

   • Jennifer M. Yamamoto
   • Jamie L. Benham
   • Lois E. Donovan

   Article 05 July 2019 Pages: 1561 - 1574

   

7. Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

   • Peter Gæde
   • Jens Oellgaard
   • Oluf Pedersen

   Short Communication Open access 01 June 2019 Pages: 1575 - 1580

   

8. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study

   • Adela Brahimaj
   • Fernando Rivadeneira
   • Maryam Kavousi

   Article Open access 10 June 2019 Pages: 1581 - 1590

   

9. Urinary bisphenol A concentration and glucose homeostasis in non-diabetic adults: a repeated-measures, longitudinal study

   • Bin Wang
   • Mian Li
   • Guang Ning

   Article 15 May 2019 Pages: 1591 - 1600

   

10. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium

    • Robert W. Koivula
    • Ian M. Forgie
    • for the IMI DIRECT Consortium

    Article Open access 15 June 2019 Pages: 1601 - 1615

    

11. Biomarker panels associated with progression of renal disease in type 1 diabetes

    • Marco Colombo
    • Erkka Valo
    • on behalf of the FinnDiane Study Group and the Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Collaboration

    Article Open access 20 June 2019 Pages: 1616 - 1627

    

12. Birthweight and early-onset type 2 diabetes in American Indians: differential effects in adolescents and young adults and additive effects of genotype, BMI and maternal diabetes

    • Muideen T. Olaiya
    • Lauren E. Wedekind
    • William C. Knowler

    Article 20 May 2019 Pages: 1628 - 1637

    

13. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study

    • Shiu Lun Au Yeung
    • Shan Luo
    • C. Mary Schooling

    Article 03 June 2019 Pages: 1638 - 1646

    

14. Association of CREBRF variants with obesity and diabetes in Pacific Islanders from Guam and Saipan

    • Robert L. Hanson
    • Saied Safabakhsh
    • Robert G. Nelson

    Short Communication 06 July 2019 Pages: 1647 - 1652

    

15. miR-17-92 and miR-106b-25 clusters regulate beta cell mitotic checkpoint and insulin secretion in mice

    • Amitai D. Mandelbaum
    • Sharon Kredo-Russo
    • Eran Hornstein

    Article 11 June 2019 Pages: 1653 - 1666

    

16. Oestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells

    • Juan Martinez-Pinna
    • Laura Marroqui
    • Angel Nadal

    Article 27 June 2019 Pages: 1667 - 1680

    

17. Circulating CXCR5⁻PD-1^hi peripheral T helper cells are associated with progression to type 1 diabetes

    • Ilse Ekman
    • Emmi-Leena Ihantola
    • Tuure Kinnunen

    Article Open access 03 July 2019 Pages: 1681 - 1688

    

18. Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice

    • Camilla H. F. Hansen
    • Christian S. Larsen
    • Axel K. Hansen

    Article 28 May 2019 Pages: 1689 - 1700

    

19. Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes

    • Myo Myo Aung
    • Kate Slade
    • Kim M. Gooding

    Article Open access 16 June 2019 Pages: 1701 - 1711

    

20. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse

    • Jay C. Jha
    • Aozhi Dai
    • Karin A. M. Jandeleit-Dahm

    Article 20 June 2019 Pages: 1712 - 1726

    

21. CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor

    • Philippe P. Pagni
    • Anitra Wolf
    • Ken Coppieters

    Letter 17 May 2019 Pages: 1727 - 1729

    

22. CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter]

    • Gisela M. Vaitaitis
    • Michael H. Olmstead
    • David H. Wagner Jr.

    Letter 08 July 2019 Pages: 1730 - 1731

23. Blood Mg²⁺ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study

    • Peter R. van Dijk
    • Joëlle C. Schutten
    • Robin P. F. Dullaart

    Letter 27 June 2019 Pages: 1732 - 1734